Skip to content

LIGHTMind 2: Low-intensity guided help through mindfulness

Low-Intensity Guided Help Through MINDfulness: A randomised controlled trial comparing supported mindfulness-based cognitive therapy self-help to supported cognitive behaviour therapy self-help for adults experiencing depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN13495752
Enrollment
410
Registered
2017-08-31
Start date
2017-09-11
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Specialty: Mental Health, Primary sub-specialty: Depression

Interventions

This is a parallel groups, superiority pragmatic RCT with 1:1 allocation to MBCT-SH or CBT-SH with blinded assessments at all time points. Participants are blind to the hypothesised direction of effec

Sponsors

Sussex Partnership NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Be aged 18 years or over 2. Meet diagnostic criteria on the revised Clinical Interview Schedule (CIS-R) for a primary diagnosis of a depressive episode, or mixed anxiety and depression 3. Score 10 or more on the PHQ-9 at their initial IAPT assessment (the cut-off for a major depressive episode); and 4. Have sufficient literacy skills to read and understand the self-help materials

Exclusion criteria

Exclusion criteria: 1. Have severe symptoms of depression (a score 20 or more on the PHQ-9); 2. Score of 4 on the CIS-R suicidality scale 3. Express a strong preference (5/5) for one intervention over the other on the Treatment Preference 5. Question such that if randomised to the non-preferred intervention they would be likely to drop out of the intervention.

Design outcomes

Secondary

MeasureTime frame
1. Depression symptom severity is measured using the change in PHQ-9 score from baseline to follow-up (42 weeks post-randomisation) is a secondary outcome for the study at follow-up 2. Generalised anxiety is measured using the GAD-7 is a 7-item measure of generalised anxiety used in IAPT. Items are rated on a 4-point scale and the measure has excellent psychometric properties from baseline to post-intervention and from baseline to follow-up 3. Wellbeing is measured using the short version of the Warwick Edinburgh Mental Wellbeing Scale consists of 7 questions rated on a 5-point scale designed to measure wellbeing from baseline to post-intervention and from baseline to follow-up are secondary outcomes 4. Functioning is measured using the Work and Social Adjustment Scale (WSAS) is a 5-item measure of daily occupational and social functioning that is used routinely in IAPT from baseline to post-intervention and from baseline to follow-up are secondary outcomes 5. Mindfulness is measured using the 15-item version of the Five-Facet Mindfulness Questionnaire. from baseline to post-intervention and from baseline to follow-up are secondary outcomes 6. Service use is measured using the a self-report version of the Adult Service Use Schedule (ADSUS) will be used to collect data on resource used to estimate costs and will take the health and social services perspective at collected at baseline, post-intervention (16 weeks post-randomisation) and follow-up (42 weeks post-randomisation) 7. Health-related quality of life is measured using the EQ-5D is a five-dimension, generic, preference-based measure of health-related quality of life covering mobility, self-care, usual activities, pain/discomfort and anxiety/depression.at baseline, post-intervention (16 weeks post-randomisation) and follow-up (42 weeks post-randomisation). Qualitative Evaluation: The

Primary

MeasureTime frame
Depression symptom severity at post-intervention. The PHQ-9 is a 9-item self-report measure of depression symptom severity used in all IAPT services. Items are rated on a four-point scale. The primary outcome for this study is change in PHQ-9 score from baseline to 16 weeks post-randomisation

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 27, 2026